GENOMIC PROFILING OF SMOLDERING MULTIPLE MYELOMA IDENTIFIES PATIENTS AT A HIGH RISK OF DISEASE PROGRESSION
Smoldering multiple myeloma (SMM) is a precursor condition of multiple myeloma (MM) with a 10% annual risk of progression. Various prognostic models exist for risk stratification; however, those are based on solely clinical metrics. The discovery of genomic alterations that underlie disease progression to MM could improve current risk models. We observed that most of […]
